Accessibility Menu

Lsl Pharma Group(TSXV) LSL

Market CapCA$40.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2023)-57%
5 YearN/A
1 Year-14%
1 Month-11%
CA$0.34
+4.69%
+0.02Today
Lsl Pharma Group last closing stock price
MetricPriceDate
Last closeCAD 0.342026-08-31
Lsl Pharma Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.29%CAD 0.352026-08-24
1 month-10.67%CAD 0.382026-07-31
3 month+1.52%CAD 0.332026-06-02
Year to date-4.29%CAD 0.352025-12-31
1 year-14.1%CAD 0.392025-08-29
3 year-31.63%CAD 0.492023-08-31
Since inception-57.33%CAD 0.752023-03-02

Lsl Pharma Group Financials at a Glance

Market Cap

CA$40.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$41.83

Net Income (TTM)

-CA$7.34

EPS (TTM)

-CA$0.06

P/E Ratio

-5.46

Dividend

CA$0.00

Beta (Volatility)

0.12 (Low)

Price

CA$0.34

Volume

31,000

Open

CA$0.33

Previous Close

CA$0.34

Daily Range

CA$0.33 - CA$0.34

52-Week Range

CA$0.30 - CA$0.56

Estimated Earnings Date

N/A

LSL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lsl Pharma Group

LSL Pharma Group, Inc. operates as a pharmaceutical company. It specializes in the development, manufacture and distribution of natural health products and dietary supplements in solid dosage forms as well as sterile ophthalmic pharmaceutical products. The company was founded on July 12, 2010 and is headquartered in Boucherville, Canada.

Industry

Personal Products

Sector

Consumer Staples

CEO

François Roberge

Website

www.groupelslpharma.com

LSL Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-31.63%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-18.32%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

CA$40.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

126.73M

Volume

31.00K

Avg. Volume

72.39K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Lsl Pharma Group Performance Analysis

Lsl Pharma Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-07-31CAD 0N/A
20232023-12-31CAD 10,028,000N/A
20242024-12-31CAD 17,748,00077.0%
20252025-12-31CAD 28,744,00062.0%
Lsl Pharma Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-07-31CAD -0.09N/A
20232023-12-31CAD -0.1117.4%
20242024-12-31CAD 0.03N/A
20252025-12-31CAD -0.02N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$14.63

+2.0%

Gross Profit

CA$1.31

+0.7%

Gross Margin

8.95%

+0.4%

Market Cap

CA$40.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

-CA$2.24

+5.8%

EBITDA

-CA$0.03

-0.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$51.56

+55.9%

Total Debt

CA$50.59

+1.8%

Accounts Receivable

CA$7.92

+1.5%

Inventory

CA$17.07

+1.4%

Long Term Debt

CA$38.17

+2.2%

Short Term Debt

CA$12.42

+1.2%

Return on Assets

-9.85%

-1.4%

Return on Invested Capital

-16.75%

+0.7%

Free Cash Flow

-CA$0.01

-0.0%

Operating Cash Flow

CA$0.40

+0.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About LSL

What is the current price of Lsl Pharma Group?

Lsl Pharma Group is trading at CA$0.34 per share.

What is the 52-week range for Lsl Pharma Group?

Over the past 52 weeks, Lsl Pharma Group has traded between CA$0.30 and CA$0.56.

How much debt does Lsl Pharma Group have?

As of the most recent reporting period, Lsl Pharma Group reported total debt of CA$50.59M.

How much cash does Lsl Pharma Group have on hand?

Lsl Pharma Group reported CA$967.00K in cash and cash equivalents in its most recent financial results.

What is Lsl Pharma Group’s dividend yield?

Lsl Pharma Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services